FLAMINGO: how much rosier can antiretroviral therapy get?

被引：4

作者：

Pozniak, Anton L. ^{[1
,2
]}

Arribas, Jose R. ^{[3
]}

机构：

[1] Chelsea & Westminster Hosp NHS Fdn Trust, HIV Directorate, London SW10 9NH, England

[2] Univ London Imperial Coll Sci Technol & Med, London, England

[3] Hosp La Paz, IdiPAZ, Madrid, Spain

来源：

LANCET | 2014年 / 383卷 / 9936期

关键词：

HIV-1; INFECTION; DOUBLE-BLIND; DOLUTEGRAVIR; RALTEGRAVIR;

D O I：

10.1016/S0140-6736(14)60447-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2191 / 2193

页数：4

共 11 条

[1]

[Anonymous], LANCET

[2] Advances in antiretroviral therapy [J].

Arribas, Jose R. ;

Eron, Joseph .

CURRENT OPINION IN HIV AND AIDS, 2013, 8 (04) :341-349

[3]

European AIDS Clinical Society, 2013, EACS TREATM GUID VER

[4] A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects [J].

Koteff, Justin ;

Borland, Julie ;

Chen, Shuguang ;

Song, Ivy ;

Peppercorn, Amanda ;

Koshiba, Takaaki ;

Cannon, Courtney ;

Muster, Heather ;

Piscitelli, Stephen C. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) :990-996

[5] Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial [J].

Lennox, Jeffrey L. ;

Dejesus, Edwin ;

Lazzarin, Adriano ;

Pollard, Richard B. ;

Ramalho Madruga, Jose Valdez ;

Berger, Daniel S. ;

Zhao, Jing ;

Xu, Xio ;

Williams-Diaz, Angela ;

Rodgers, Anthony J. ;

Barnard, Richard J. O. ;

Miller, Michael D. ;

DiNubile, Mark J. ;

Nguyen, Bach-Yen ;

Leavitt, Randi ;

Sklar, Peter .

LANCET, 2009, 374 (9692) :796-806

[6] A Systematic Review and Meta-regression of Temporal Trends in Adult CD4+ Cell Count at Presentation to HIV Care, 1992-2011 [J].

Lesko, Catherine R. ;

Cole, Stephen R. ;

Zinski, Anne ;

Poole, Charles ;

Mugavero, Michael J. .

CLINICAL INFECTIOUS DISEASES, 2013, 57 (07) :1027-1037

[7] Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis [J].

Mathis, Sandra ;

Khanlari, Bettina ;

Pulido, Federico ;

Schechter, Mauro ;

Negredo, Eugenia ;

Nelson, Mark ;

Vernazza, Pietro ;

Cahn, Pedro ;

Meynard, Jean-Luc ;

Arribas, Jose ;

Bucher, Heiner C. .

PLOS ONE, 2011, 6 (07)

[8]

Mollan K, 2013, IDWEEK 2013 OCT 2 6

[9] Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study [J].

Raffi, Francois ;

Rachlis, Anita ;

Stellbrink, Hans-Juergen ;

Hardy, W. David ;

Torti, Carlo ;

Orkin, Chloe ;

Bloch, Mark ;

Podzamczer, Daniel ;

Pokrovsky, Vadim ;

Pulido, Federico ;

Almond, Steve ;

Margolis, David ;

Brennan, Clare ;

Min, Sherene .

LANCET, 2013, 381 (9868) :735-743

[10]

US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1

← 1 2 →